HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MRT12113

a protease inhibitor

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - MRT12113: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - MRT12113: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        MRT12113: 1

Experts

1.	Kalwani, Vishal: 1 article (01/2014)
2.	Mohanasrinivasan, V: 1 article (01/2014)
3.	Ravikumar, Pranali: 1 article (01/2014)
4.	Srivastava, Saumya: 1 article (01/2014)
5.	Subathra Devi, C: 1 article (01/2014)
6.	Tandon, Aishwarya: 1 article (01/2014)
7.	Verma, Priyanka: 1 article (01/2014)

Related Diseases

1.	Rupture 01/01/2014 - "To control infection, a drug-cover of artemisinin will be administered as a part of the vaccination strategy along with a specific protease inhibitor MRT12113 which prevents RBC rupture and reinvasion by the parasite. "

Related Drugs and Biologics

1.	Protease Inhibitors (Protease Inhibitor)
2.	artemisinin (artemisinine)